Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Experiential account experience in the prison
1. Dr Sonali Jhanjee, Additional Professor
National Drug Dependence Treatment Centre,
AIIMS
National CME: OST , 19.04.15
Experiential account:
Experience in the prison
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
2. Why should we think
about OST in
Prison?
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
3. Why should we think about it?...
Strong connection between criminal activity and substance
abuse.
Chaiken 1986; Inciardi 1979; Johnsonet al. 1985
Percentage of people with a drug problem in prison ranges
from 40 to 80%
Dolan K,, Brentari, C, and Stevens A 2008
Problematic substance misuse is overrepresented in prison as
compared to the community.
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
4. There are drugs in prison…
Prisons are ‘secure’ establishments
However drugs are available in prisons throughout the world.
Presence of drugs can be a difficult issue for prison authorities
to officially acknowledge.
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
5. Prisoners experience drug problems before,
during and after imprisonment…
Pure criminal justice interventions, without associated drug
treatment:
Have very limited impact on drug-using behaviour
Between 70 and 98 % of those imprisoned for drug-related crimes
and not treated relapsed within the year following release
re-offending
(WHO, Status Paper on Prisons,2005)
The risk of a fatal overdose in the first few days following
release from prison:
In a UK study of 51,590 releases from prison, approx 35% of all male
and 12% of all female drug related deaths are from prisoners recently
released.
(Farrell & Marsden 2005)Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
6. Prisons and prisoners are part of our
community…
A large percentage of prisoners serve short prison terms of less
than one year.
Prisoner health is community health- rapid turnover, sharing,
unprotected sex, both inside prison and back in the community
A significant number of these will reoffend and return to prison,
creating a “revolving door” between prison and the community.
Prison health challenges do not ‘stay behind bars’…
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
7. A unique opportunity
Unique opportunity for health promotion, intervention and
disease prevention providing access to ‘hard to reach’ groups.
In the absence of effective treatment -high proportion of drug
dependent prisoners will continue using drugs and persist in
crime.
Drug dependence treatment works…
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
9. Attitudinal barriers
Denial of drug abuse problem in prison
Common perception that prisons should be drug-free zones
Moral failing of individual vs chronic relapsing disorder
Treatment programs often encounter opposition because
they run counter to the established punishment/ control
culture in correctional settings
OST undermines their efforts to reduce the drug supply in
their institutions (ie, a black market for drugs)
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
11. Background
UNODC-ROSA (funding agency)
Project:“Prevention of Spread of
HIV amongst vulnerable groups in
South Asia(RAS/H71)”
Component:Advocating for and
Provision of Oral Substitution
Treatment (OST) in Prisons of
South Asia
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
12. Advocacy
Breaking
Denial
Training &
Sensitization
Peer
networking &
peer led
intervention-
involving
Prison staff,
inmates, NGOs
Building
partnerships-
prison
officials, civil
society,
prisoners
Breaking
the “Us”
and
“Them”
Divide
Hand Holding for
acceptance of a
comprehensive
package
of services for
HIV prevention
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
13. Study Intervention site (Tihar Prisons)
Delhi Prisons has two Prison Complexes
Tihar
one of the largest prison complex in the world comprising
of nine central prisons
District Prison at Rohini Prison Complex
Houses 12000 prisoners against sanctioned capacity of 6250
prisoners
First intervention In a South Asian Prison
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
14. Objectives
To test the feasibility and effectiveness of buprenorphine as
medication for long term treatment for opioid dependence in
Tihar prisons
To develop a manual/ protocol of guidelines for implementing
OST in prisons settings
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
15. Training
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
16. Agenda
Overview of OST (opioid substitution therapy)
Minimum standards of practice and best practices in OST
delivery
Safeguards
overdose prevention and management
prevention and minimization of diversion
Issues related to implementation in prison setting
Participative group session
Drafting road map for implementation of OST in Tihar prison
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
18. Human Resources and Training
Existing health structure and human resources of the Tihar
prison was utilized for training.
Doctors and nurses already working in prison were deputed
for the programme and trained in the delivery of OST.
Existing lab personnel of Tihar were trained to carry out urine
screening for morphine.
Counselors to deliver psychosocial interventions were trained
from NGOs working in Tihar prisons.
Personnel from the prison administration were sensitized to
address organizational issues and provide administrative
support for the programme.
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
19. Training
The trainings were provided by psychiatrists and faculty of
Clinical chemistry from NDDTC, who had technical expertise
and wide experience in administration of OST in the
community setting in India.
The training was participatory and multi-modality and on-site
exposure to patients receiving Buprenorphine in the
community was provided.
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
20. Training
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
21. Agenda
Role definition
Detailed pharmacology of Buprenorphine
Demonstration of Psychosocial interventions to be carried out
Clarification of dispensing to doctors/nurses and prison
managers
Explanation about maintenance of stock registers to nurs
Interaction with patients already receiving OST in Trilokpuri
community clinic
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
22. Training
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
23. Training
Formally inaugurated by hon,ble Mr.Tejendra Khanna, Lt. Governor, Delhi
Hands on practical training as and when required
Weekly visits to Tihar jailPresented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
24. Site of Implementation
The site of implementation was the de-addiction center
located in the premises of the Tihar Jail Complex of Delhi
Prisons.
The deaddcition centre is a 120 bedded hospital. Prisoners on
OST were housed exclusively in one ward of the hospital.
This was done with a view to make it easier for prison
administration to coordinate and deliver OST services from
one single point
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
25. Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
26. Service Delivery
Three common situations where it is appropriate to initiate
users on to opiate maintenance in the prison setting are
immediately
upon admission to prison
during the sentence
a period of time before release.
In this study, opioid dependent prisoners were identified at
the initial medical examination upon admission into prisons
and eligible opioid dependent inmates from Tihar prisons
were offered pharmacotherapy with buprenorphine and
psychosocial intervention.
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
27. Intervention
OST (Buprenorphine)
• Intiate daily dispensing in
prison
• Continue post release in
community at
• NDDTC, Ghaziabad,AIIMS
• Community clinic,Trilokpuri,
AIIMS
• Mobile clinic, Sundarnagari,
AIIMS
• Psychiatry OPD,AIIMS
Psychosocial intervention
• Administered in group sessions
and individual sessions
• By trained NGO’s operating at
Tihar prison regarding
• Goals of maintenance
treatment
• Treatment compliance
• Relapse prevention
• Coping and problem solving
skills
• High risk behavior
• Motivation enhancement
• Lifestyle changes
• Rehabilitation
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
28. Methodology
Design
• Pre-post design with assessments (on predetermined
parameters) at
• Baseline
• 3 months
• 6 months
• 9 months and
• 12 months
Post release
• On release, patients assigned a designated follow up centre
(closest to their residence) to continue OST
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
29. Inclusion criteria
Age > 18 years
Likely to stay in prison for one year
ICD-10 diagnosis for Opioid dependence (as per self
report) at the time of incarceration
(Preference would be given to those IDU’s who are HIV/ hepatitis B/
hepatitis C +ve)
History of opioid dependence for ≥ 5 years
Staying near or willing to follow up in a community centre
Willing to participate voluntarily and provide informed
consent
Priority given to patients already receiving OST in the
community upon imprisonment
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
30. Source: International Centre for Prison Studies, London, 2005
Countries Remand prisoners and/or
pre-trial detainees as % of all
prisoners
India 70
Bangladesh 60
Sri Lanka 48
Nepal 60
Maldives NA
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
31. Daily Dispensing
Buprenorphine was given as daily Directly Observed Treatment
(DOT) sublingually.
The medication was dispensed early in the morning to
minimize disruption of their daily activities of the prisoners
including legal visits and allotted work.
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
32. Baseline
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
33. Socio-Demographic Profile
Age: 83% in 18-35 years age group
40% in 18-25 years
43% in 26-35 years
Mean age of the sample 29.2 ± 8.1 yrs
Marital status: 71% were single
56.4% unmarried
14.3 % were either divorced or separated due to drug use
Sizeable number were illiterate (47.4%) followed by those
who were literate / educated up to only the middle level (33%)
65%: either presently unemployed or never employed
38%: either living alone or with friends
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
34. Crime record
96%: pretrial remandees
93%: repeat offenders
Mean no. of times arrested before this crime was (6±4)
Mean age at first imprisonment 20±6 years
Majority (81%) NOT arrested under NDPS act
98%: committed offences to support their drug use
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
35. Drug use profile
Mean age of initiation of primary drug is 18 +5 yrs
In 37%, age of onset, before 15 years
The mean duration of regular use 10+7 yrs
70.5% were currently (1month prior to imprisonment) IDUs
Sharing of syringe/needle: 85%
Sharing of paraphrenalia: 67%
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
36. 0
20
40
60
80
100
Ever use
Prior to imprisonment
Drug use among prisoners
Most were poly drug users with heroin being the primary drug in 97%
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
37. At follow-up
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
38. Treatment outcome at time of release
Median duration of stay in the prison: 81 days (minimum=2,
maximum=715, s.d. =152)
95.5% retention rate in prison
100 % compliance among those retained in prison
3 months 6 months 9 months 12 months
Mean dose of
Buprenorphine
(in mg)
5.1± 2.4 4.8± 2.1 3.8 ±1.1 3.3± 1.4
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
39. Drug use
3 prisoners reported IDU at follow up
Majority reported not using any illicit drugs on follow up
4% reported heroin use
5% reported Cannabis use
Objectively confirmed by urine screening
47% continued use of tobacco within prison setting although
not on a daily basis
Marked decline in drug use
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
40. Lab parameters: urine screening
•6% of sample tested positive at 3 months
•None tested positive at 6, 9 and 12 months
follow-up
N=133
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
41. 7.7
1.3
0.8 0.9
0.0
0
1
2
3
4
5
6
7
8
9
at Beginning 3 months 6 months 9 months 12 months
A significant decrease (F=39.94,df=4,p<.001) in severity of dependence of drug use
was reported over time
Mean score of severity of dependence of the
inmates over time
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
42. Withdrawal symptoms
Mean Subjective Opioid Withdrawal
Scale score (SOWS)
Mean Objective Opioid Withdrawal
Scale score(OOWS)
38.3
8.5
3.1
0.3 1.4
0
5
10
15
20
25
30
35
40
45
A highly significant
decrease(F=182.19, df=4,
p<.001) was observed over time
5.0
2.2
0.6
1.2
0.0
0
1
2
3
4
5
6
Baseline 3
months
6
months
9
months
12
months
A highly significant
decrease(F=22.97, df=4, p<.001)
was observed over time
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
43. 7.5
0.8
0.6
0.0 0.0
0.0
1.0
2.0
3.0
4.0
5.0
6.0
7.0
8.0
Baseline 3 months 6 months 9 months 12 months
A highly significant decrease (F=121.73, df=4,
p<.001) was observed over time.
Mean visual analog (VAS) score for craving
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
44. Side effects
OST with buprenorphine demonstrated to be safe
No major adverse events reported during implementation
Buprenorphine well tolerated
Minor side effects like headaches, light headedness,
drowsiness and weakness reported at 3 months and were
minimal at 6 months followup
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
45. Diversion
Diversion noted at the initial stages of the project
No diversion reported in the past year
To prevent diversion
Medications dispensed in small batches of 3-5 prisoners
Supervision by doctors, nurse with one staff from the jail
administration
Tablets were crushed before dispensing
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
46. Safe keeping of Buprenorphine
Safe keeping of Buprenorphine was ensured and bulk stock of
medication was stored in the head office of the prison and a
stock of few days medication was maintained at the site of
dispensing.
Mechanisms were put in place to ensure that the supply chain
of buprenorphine is well maintained.
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
47. Monitoring of provision
Intensive mentoring inputs were provided from the technical
experts from NDDTC during this period who made weekly site
visits to hand hold the provision of OST and monitor the
difficulties encountered/solve operational problems during the
first 6-8 months.
Once mechanisms of delivery were established, these visits
were made fortnightly and later monthly.
Further, telephonic contact with technical agency was always
made available
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
48. Pre-release planning
It is well known that the continuity of treatment for
prisoners as they re-enter the community is of critical
importance to prevent death by overdose and reduce
relapse to heroin use,
community linkages were secured at the start of the
study.
On release the prisoner was provided with referral slips
for follow up to the appropriate community centre
indicating that the date of commencement of opioid
substitution therapy and current dose of Buprenorphine.
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
49. Pre-release planning
Midway through the project, it was realized that a two days
take away dose of the buprenorphine naloxone combination
on release from prison may be provided to the prisoners upon
their release to offset the risk of relapse.
This allowed the released prisoner some time to locate his
follow up center in the community and also provided cover for
holidays.
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
50. Qualitative data- Staff
Initial 3 months of the program were very difficult due to
coordination problems both the staff and patient.
Perceived increased workload was causing difficulties.
It took an initial 3months for all of them to comfortable with
each other and all procedures to fall in place
Duties of staff adjusted to accommodate increased
responsibility
Rapport with patients is much better, they respect the staff
members and listen to what they have to say.
“Insaan ban gaye”
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
51. Changes noted in patients behaviour
Marked improvement in personal hygiene
Take a bath, shave ,wash clothes
Marked improvement in irritability and disciplinary problems
Are amenable to counselling
More responsible Do the work alloted to them
Look after new OST prisoners
Listen to what the staff members are saying
EAT!
A positive change in behavior reported by jail authorities.
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
52. Patients
Subjective report of patients being relieved, comfortable reporting no
craving, withdrawl or irritability.
They can finally focus on other issues.
First ray of hope that treatment is possible.
Satisfied with treatment and attitude of staff
Were satisfied with the dosage of drug provided.
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
53. Issues and challenges
A major challenge in the implementation of this project was
the unpredictable duration of stay (mostly short) and
unplanned release of these inmates as overwhelming majority
was pretrial remand prisoners and not convicts.
The available time for therapeutic intervention was often
short.
Therefore the designated follow up community center was
communicated to the inmate at the time at the time of
induction itself and a referral slip to the community center was
provided on discharge.
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
54. Refresher trainings
It was also realized that maintaining a trained workforce in
prison may require continuous effort as rotation of staff was a
norm.
Provision of periodic refresher trainings were required which
besides training new personnel, incorporated a review of
internal coordinating mechanisms between health personnel,
counselors and prison administration staff to ensure smooth
delivery of OST intervention.
Provision of these trainings also helped to maintain
momentum of OST intervention program and helped to keep
the team motivated.
Periodic refresher trainings were found to be an important
component of the overall programme.
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
55. Post release
A further observation of the project was that despite having
successful in prison outcomes, there was high rate of attrition
post release even though community linkages were secured.
This may imply that to prevent relapse into crime and drug use
people additionally need adequate support with overall social
integration(Mourino,1994)..
There was a strong expressed need for rehabilitation both in
prison and on release by prisoners. Thus mechanisms of
strengthening the post release arm of treatment needs to be
explored and formulated.
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
56. High Rate of attrition post release
Although facilitated entry in treatment but retention rates were low
Reasons
Transportation charges/financial/unemployment
Follow up centres very far
Peer pressure
Involvement in criminal activities
Lack of family support/family wants patient to continue criminal
activities as source of income/family involved in drug peddling/
Lack of residence
Trilokpuri centre near police station
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
57. What did we achieve in the
prisons?
Demonstrated that the intervention if feasible
Achievements in jail
• Abstinence from illicit drugs as confirmed by periodic urine screening
• Decrease in craving and withdrawl of drugs
• No drug seeking behaviour
• Decreased high risk behaviour
• Retention in treatment in prison
• Positive changes in institutional behaviour including increased
productivity
• Information, education and communication on HIV and related risk
behaviours
• First exposure to maintainence treatment
• Counseling regarding nature of OST and relapse prevention counseling
Coordination of prison health staff and administration essential
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
58. Conclusion
This collaborative project was implemented in Tihar prisons
from 2008-12.
Overall, this project was a significant regional advance as it
demonstrated that it is feasible to implement OST in prisons
and support from both, prison administration and health
services is critical to implement this programme.
This project has also helped to develop the Standard
Operating Procedures to be followed for OST within prison
settings.
The effectiveness of OST was demonstrated in prison settings
and this OST model was also “presented” (through study visits)
to Government counterparts from other countries of South
Asia.
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
59. Where do we go from here?
Scale up
nationally and
regionally
SOP laid down
for
implementation
Develop
models of
community
linkages
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
60. Future directions
• Acknowledge problem in national policies
• Assess extent of the problem
• Implement comprehensive and standardized screening and
assessment process
• Match inmates to appropriate treatment programs based on
their individual needs and severity of substance abuse
• Develop policies and procedures for providing clinical
supervision to treatment and evaluation
• Develop models of community integration
Do we need to send them to Prison at all???
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
61. Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
62. Acknowledgements
Mr. B.K Gupta (ex- DG prison)
Mr. Neeraj kumar (DG prison)
Dr. Girdhar, RMOTihar prisons
Project team at NDDTC AIIMS
UNODC-ROSA
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
63. Needle and Syringe Programmes (NSP)
Opioid SubstitutionTherapy (OST)
Voluntary HIV Counselling andTesting (VCT)
Anti-RetroviralTherapy (ART)
SexuallyTransmitted Infections (STI) prevention
Condom programming for IDUs and partners
Targeted Information, Education and Communication
(IEC) for IDUs and their sexual partners
Hepatitis diagnosis, treatment (Hepatitis A, B and C) and
vaccination (Hepatitis A and B)
Tuberculosis (TB) prevention, diagnosis and treatment.
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
64. THE NARCOTIC DRUGS AND PSYCHOTROPIC
SUBSTANCES (NDPS) ACT,
1985-
Under section 64 A, any addict, who is
charged with an offence punishable under
section 27 or with offences involving small
quantity of narcotic drugs or psychotropic
substances, who voluntarily seeks to undergo
medical treatment for de-addiction
from a hospital or an institution maintained
or recognized by the Government or a local
authority and undergoes such treatment
shall not be liable to prosecution under
section 27 or any other section for offences
involving small quantity of narcotic drugs
and psychotropic substances.This immunity
may be withdrawn if the addict does
not undergo the complete treatment for deaddiction.
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
65. THE NARCOTIC DRUGS AND PSYCHOTROPIC
SUBSTANCES (NDPS) ACT,
1985-
. Section 71 of this act, empowers government
to establish centers for identification,
treatment, education, after care, rehabilitation,
social reintegration of addicts and
for supply, of any narcotic drugs and psychotropic
substance (as prescribed by concerned
Government) to the addicts registered
with government and to others where
such supply is a medical necessity
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi
66. N A T I O N A L P O L I CY O N NA R C OT I C
D R U G S A N D P SY C H OT R O PI C
S U B S T A N C E S
The primary purpose of these [drug court] programs is
to use a court's authority to reduce crime by changing
defendants’ substance abuse behavior. In exchange for the
possibility of dismissed charges or reduced sentences,
eligible defendants who agree to participate are diverted
to drug court programs in various ways and at various
stages in the judicial process.These programs are typically
offered to defendants as an alternative to probation or
short-term incarceration." - See more at:
http://www.drugwarfacts.org/cms/Drug_Courts#overview
Presented at the national CME "OST: Policy and Practice" on 18th-19th April 2015 at AIIMS, New Delhi